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Puromycin aminonucleoside inhibits mesangial cell-induced
contraction of collagen gels by stimulating production of reactive
oxygen species
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Puromycin aminonucleoside inhibits mesangial cell-induced contrac-
tion of collagen gels by stimulating production of reactive oxygen species.
Glomerular epithelial cell injuly is thought to be the primary reason for
the development of proteinuria in puromycin aminonucleoside nephrosis
(PAN), the rat model of nephrotic syndrome. By comparison mesangial
cells are considered resistant to the effects of puromycin. The purpose of
the present study was to investigate whether puromycin in non cytotoxic
concentrations caused mesangial cell dysfunction, with particular refer-
ence to cell-extracellular matrix interactions. Mesangial cells, when em-
bedded in collagen gels, contract after exposure to minimal essential
medium (MEM) containing fetal bovine serum (FBS). This contractility,
measured by determining changes in area of the collagen gel, is inhibited
by puromycin in a dose dependant manner from 2.5 g/ml to 160 .tg/ml.
At these concentrations there is no alteration of cell viability as measured
by the tetrazolium salt (Mfl') method and trypan blue exclusion. Immu-
nocytochemistry with rhodamine phalloidin reveals that actin filaments
are not disrupted. The antioxidants, superoxide dismutase (SOD) and
catalase as well as diphenylene iodonium (DPI), a flavoprotein inhibitor,
not only counteracted the effect of puromycin on gel contraction, but also
enhanced gel contraction when added to mesangial cells on their own.
Aminotriazole, an inhibitor of endogenous catalase, inhibited mesangial
cell-induced gel contraction in a dose dependent manner (5 mM to 40
mM), and this effect was completely reversed by addition of catalase.
Mesangial cells preloaded with dihydrorhodamine and exposed to puro-
mycin (5 gJml to 160 Wml) exhibited a dose dependent increase in
rhodamine 123 fluorescence, indicating production of reactive oxygen
species (ROS). This effect was blocked by the addition of DPI. We
conclude that: (i) puromycin, in concentrations similar to those that cause
glomerular epithelial cell changes in vitro, also inhibits mesangial cell-
induced contractility in collagen gels; (ii) endogenous ROS production by
mesangial cells inhibits their ability to contract collagen gels; and (iii)
mesangial cells stimulated by puromycin produce increased amounts of
ROS which causes inhibition of mesangial cell-collagen gel contraction.
Thus mesangial cells may play a previously unrecognized role in the
pathogenesis of PAN, either directly through ROS-induced mesangial cell
dysfunction or indirectly through increased production of ROS and
secondary damage to adjacent glomerular epithelial cells.
Puromycin aminonucleoside nephrosis in rats has been exten-
sively used as a model to understand the pathogenesis of ne-
phrotic syndrome in humans, particularly minimal change glomer-
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ulonephritis. The glomerular epithelial cell appears to be the
primasy cellular target in PAN. Within 24 hours of parenteral
administration of puromycin, albuminuria occurs and proteinuria
ensues by 48 hours [11. There are detectable alterations of the
width of the podocyte foot processes within 24 hours, and after 48
hours the loss of foot process structure is marked. Podocyte
cytoskeletal disaggregation and detachment of the glomerular
epithelial cell from the basement membrane is most severe on day
5 [1]. These morphological changes are accompanied by a de-
crease in proteoglycan and increased collagen I, laminin and
fibronectin mRNA level expression in the glomerular basement
membrane within the first 48 hours [2]. Cultured glomerular
epithelial cells are also affected by puromycin in both a time and
dose dependant manner, with increasingly severe cell injury noted
at concentrations between 25 .tg/ml and 400 .tWml [3].
Reactive oxygen species (ROS), which include H202 and 02,
are highly reactive oxidizing agents that can damage cellular
components of cells. They have been implicated in the pathogen-
esis of PAN both in vitro and in vivo [4]. Increased amounts of
ROS have been measured in whole glomeruli in adriamycin-
induced nephrotic syndrome which may be analogous to PAN [5],
and ROS are also produced by cultured kidney slices exposed to
puromycin [6]. Cultured glomerular epithelial cells exposed to
puromycin produce H2O2, and toxicity produced by this oxidizing
agent can be reversed by the antioxidants catalase and desferri-
oxamine [3]. In the rat puromycin model, administration of the
antioxidants, SOD and allopurinol, reduced proteinuria and pre-
vented glomerular injury [7]. Taken together there is substantial
evidence implicating ROS production in the pathogenesis of PAN
with the glomerular epithelial cell as the main target. Mesangial
cells on the other hand are generally considered to be resistant to
puromycin nephrotoxicity. Despite the fact that mesangial cells
are well known to produce relatively large amounts of ROS under
a variety of experimental disease conditions, comparatively little
information is available on the potential role of mesangial cells in
the pathogenesis of PAN.
Mesangial cells, similar to other cells of mesenchymal origin,
when embedded in a three dimensional type I collagen gel can be
stimulated by serum to cause a reduction in area of the collagen
gel [8—li]. This serum-induced contraction of the collagen gel
requires the cells to have an intact cytoskeleton, the ability to
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spread and migrate, to form cell substratum attachments medi-
ated by integrins, a flexible substratum and signaling pathways
linking these various components [12]. In the present study we
investigated the effect of puromycin on mesangial cells and their
interactions with extracellular matrix using an in vitro collagen gel
contraction assay. Our results indicate that puromycin, in a dose
dependent manner, inhibits mesangial cell gel contraction. More-
over, this effect is mediated by a puromycin-dependent increase in
mesangial cell production of ROS. These findings imply that the
mesangial cell may play a more significant role in the pathogenesis
of PAN than has heretofore been recognized.
Methods
Materials
Minimal essential medium (MEM), Hanks balanced salt solu-
tion (HBSS) and fetal bovine serum were supplied by Gibco
(Grande Island, NY, USA). Type I collagen, puromycin amino-
nucleoside, MIT [3,(4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazo-
hum bromidel, bovine liver catalase, superoxide dismutase
(SOD), aminotriazole, colchicine, desferrioxamine B mesylate
and allopurinol were obtained from Sigma Laboratories (St.
Louis, MO, USA). Diphenylene iodonium (DPI) was a gift from
Dr. Sergio Grinstein (Hospital for Sick Children, Toronto, On-
tario, Canada). Rhodamine-conjugated phalloidin and dihydro-
rhodamine 123 were obtained from Molecular Probes (Eugene,
OR, USA).
Tissue culture
Rat glomeruli were isolated from kidneys of three-week-old
male Sprague-Dawley rats (approximately 15 to 50 g) by the
graded sieve technique. Mesangial cells were trypsinized and
plated onto 100 mm plates, 6 well or 24 well plates in MEM
containing 15% FBS as previously described [13]. For rhodamine-
phalloidin staining cells were plated on 12 mm glass slides
positioned in wells. Experiments were performed on cells between
passages 5 and 15.
Gel contraction assay
The gel contraction assay was based on previously described
procedures [8, 14]. Mesangial cells were placed in a solution of
MEM and type I collagen which was allowed to gelate for three
hours. The substances tested were dissolved in MEM and added
for 24 hours, after which contraction of the gels was induced by
the addition 3% FBS in MEM. The degree of contraction was
measured after an additional 24 hours and quantitated. The
longest and shortest axes of the gel was measured using a
dissecting microscope (Wild-Leitz) at 16 times magnification, and
the percentage of maximal contraction was calculated using the
following formula.
% gel contraction 100 times
(area MEM treated gel — area PBS and test substance treated gel)
(area MEM treated gel — area FBS treated gel)
Cell viability studies
Cell viability was assessed by the tetrazohium salt (MIT)
method [151 as well as by trypan blue dye exclusion [8, 14, 15].
MiT colorimetric assay. Cells were cultured on 24-well plastic
plates in a concentration of iO cells/well and allowed to grow
overnight in MEM and 15% FBS. They were washed three times
in HBSS and then incubated with the various substances tested for
24 hours. Cells were washed again in HBSS and incubated with
MIT in a concentration of 1 mg/ml for two hours at 37°C. The
cells were treated with dimethyl-sulfoxide for 30 minutes. The
plates were read on a Du Pont multiwell spectrophotometer at a
wavelength of 560 nm.
Actin filament staining. Mesangial cell F-actin was visualized, as
previously described, using rhodamine-conjugated phalloidin [8,
14].
Detection of ROS produced by mesangial cells
Production of ROS from puromycin-treated mesangial cells was
examined using dihydrorhodamine which can be oxidised to the
fluorescent product rhodamine 123 [16, 17]. A stock solution of
2 m of dihydrorhodamine was prepared in dimethyl sulfoxide.
Mesangial cells cultured at a density of 105/ml in 24 well plates
were incubated for 24 hours in MEM with 30 U/ml horseradish
peroxidase and 2 m of dihydrorhodamine at 37°C. Increasing
concentrations of puromycin from 20 jLg/ml to 160 g/ml were
added to the cells. The inhibitory effect of DPI at a concentration
of 0.625 n on cells treated with puromycin was also assessed. The
cells were trypsinized and filtered through a 35 j.m filter. The
generation of rhodamine 123 was analyzed on a Becton Dickinson
FACscan with excitation at 488 nm and the fluorescence mea-
sured at 525 nm.
Statistics
All experiments were performed in duplicate and on at least
three separate occasions. The results of the contraction assays
were normalized as shown in the Methods section. The means and
standard errors of the pooled data of the contraction assays, MIT
assays and dihydrorhodamine assays were calculated and shown
graphically. The regression coefficients of these curves was deter-
mined and the significance of these regression coefficients was
compared by the Student's t-test. In Figure 4 the mean and
standard error of the assays were calculated and their significance
was compared using the Student's t-test.
Results
Effect of puromycin on mesangial cell-induced collagen gel
contraction
Mesangial cells plated within hydrated collagen I gels attached
and assumed a bipolar elongated shape. Incubation of the gel for
24 hours after the addition of MEM resulted in a small amount of
gel contraction. Addition of MEM containing FBS (final concen-
tration 3% PBS) resulted in maximal gel contraction. As demon-
strated in Figure 1, when puromycin was added to MEM in the
presence of FBS there was a dose dependant inhibition of the
FBS-induced gel contraction. In the concentration range of 5
g/ml to 160 Wml no cytotoxicity was noted, suggesting that the
inhibition of gel contraction was not simply due to impairment of
cell viability.
As an intact cytoskeleton is necessary for gel contraction [8] we
determined whether puromycin treatment of mesangial cells
disrupted the actin filaments. Cells were plated on cover slips,
treated with puromycin in concentrations up to 160 j.Lg/ml and
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Fig. 1. The dose-dependent inhibitoiy effect of puromycin on FBS-induced
mesangial cell-collagen gel contraction. Mesangial cells, embedded in
collagen gels, were treated with increasing concentrations of puromycin
for 24 hours and then exposed to 3% FBS for a further 24 hours. Percent
gel contractility was calculated using the formula outlined in the Methods
section. The data points represent the mean the standard error of three
experiments performed in duplicate.
stained with rhodamine phalloidin. The actin filaments of mesan-
gial cells were intact under these conditions (data not shown). In
other experiments, coichicine, in concentrations up to 8 nM, did
not inhibit gel contraction (data not shown), indicating that this
assay is not dependent on microtubular function.
Effect of ROS on MC-induced gel contraction
(a) The effect of aminotriazole. Our first objective was to
determine what effect, if any, ROS had on mesangial cell-
mediated gel contraction. For this purpose we studied the effect of
aminotriazole, an inhibitor of endogenous catalase, on mesangial
cells embedded in collagen gels. Treatment of cells with amino-
triazole [5, 18] results in increased H202 release into the medium
presumably due to impaired degradation of constitutively pro-
duced H202. As shown in Figure 2, when aminotriazole (5 mM to
40 mM) was added to MEM in the presence of FBS, there was a
dose dependant inhibition of the FBS-induced gel contraction in
the absence of cytotoxicity (confirmed by MTTassay and trypan
blue exclusion, data not shown). This inhibitory effect of amino-
triazole on gel contraction was completely reversed by concomi-
tant addition of catalase 0.4 mg/ml, confirming that inhibition of
gel contraction was due to an increase in endogenously produced
H202.
(b) Evidence that ROS produced by mesangial cells under normal
conditions inhibit gel contraction. To further confirm that ROS
played a role in mesangial cell collagen gel contraction we
demonstrated that the addition of antioxidants to the system
induced gel contraction in the absence of FBS. The fiavoprotein
inhibitor DPI [19, 201, catalase and the combination of catalase
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Fig. 2. The inhibitoiy effect of aminotriazole • •) on FBS-induced
mesangial cell-collagen gel contraction and its complete reversal by the
addition of 0.4 mg/mI catalase (• •). Mesangial cells were embedded
in collagen gels and % contractility calculated as described in the Methods
section. The data points represent the mean the standard error of three
experiments performed in duplicate.
and SOD each caused significant gel contraction in the absence of
FBS (Fig. 3).
Taken together the results of sections (a) and (b) above confirm
not only that ROS inhibit the ability of mesangial cells to contract
collagen gels, but also that endogenous ROS produced by mes-
angial cells under our present culture conditions are acting to
oppose collagen gel contraction.
(c) The effect of ROS scavengers on puromycin toxicity. Although
all the gel contraction assays were performed in the noncytotoxic
range of puromycin, we wished to determine whether ROS
scavengers prevent cytotoxic injury to mesangial cells in a manner
similar to that demonstrated in cultured glomerular epithelial
cells [3]. Cell viability, using MIT assays (see Methods) on
mesangial cells in the presence of puromycin alone or when
puromycin was accompanied by addition of ROS scavengers, was
assessed. To ensure that the antioxidants tested did not interfere
with the optical density reading of the assay, controls using these
substances in the absence of puromycin were performed. Mesangi-
al cells treated with the antioxidants alone gave optical density
readings similar to the control mesangial cells (data not shown).
The data shown in Figure 4 indicates that up to 160 gig/mI there
was no observable toxicity of puromycin. For concentrations
greater than 160 j.g/ml there was progressive puromycin cytotox-
icity which was largely reversed by ROS scavengers. The data of
the MIT assay correlated with the mesangial cell cyotoxicity
observed with Trypan blue exclusion staining (data not shown).
These data further suggest that puromycin treatment of mesangial
cells in vitro causes increased ROS production which in turn
affects cellular function and viability.
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Fig. 3. Induction of gel contraction by ROS scavengers SOD, catalase or
DPI in the absence of FBS. Mesangial cells were embedded in collagen as
described in the legend for Figure 1. However, no FBS was added after 24
hours. Contraction is expressed as a % relative to a gel with the addition
of MEM alone. The data points represent the mean the standard error
of three experiments performed in duplicate. *A significant (P < 0.02)
change in contraction induced by catalase, DPI and catalase/SOD when
compared to MEM alone.
(d) The effect of ROS scavengers on puromycin inhibition of gel
contraction. We next wished to determine whether or not the
inhibitory effect of puromycin on collagen gel contraction was
actually due to puromycin-induced ROS production. As a first
step the effect of ROS scavengers on puromycin treated collagen
gels was assessed. Results shown in Figure 5 demonstrate that
addition of catalase (0.4 mg/mI) and SOD (1000 ji/ml) to puro-
mycin-treated mesangial cell-collagen gels, alone or in combina-
tion, decreased the inhibitory effect of puromycin. As demon-
strated in Figure 6, DPI which inhibited flavoproteins in the
concentration 0.625 tiM, also reversed the inhibitory effect of
puromycin. In contrast, neither desferrioxamine (0.5 m to 8 mM)
nor allopurinol (0.5 n to 2 nM) reversed the inhibitory effect of
puromycin on the collagen gels (data not shown).
(e) ROS production by mesangial cells treated with puromycin.
The reversal of puromycin inhibition of gel contraction by ROS
scavengers (Figs. 5 and 6) provides indirect evidence that the
effect of puromycin was mediated by increased mesangial cell
ROS production. To directly examine whether puromycin stimu-
lated mesangial cells to produce increased ROS, the fluorescent
probe dihydrorhodamine 123 [16, 17] was used to measure
directly ROS production over 24 hours, a time frame similar to
the gel contraction assay. To ensure that the increase in fluores-
cence of rhodamine 123 was due to ROS production by mesangial
cells rather than due to the puromycin or DPI, similar experi-
ments were carried out in a cell-free system initially, with mesangi-
al cells being placed in the medium for only half an hour prior to
flow cytometry. The dihydrorhodamine fluorescence changes in
the initially cell-free system with DPI (0.625 nM) and puromycin (5
.tg/ml to 160 gJml) were similar to nonstimulated mesangial
cells. However, inspection of Figure 7 revealed that in mesangial
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Fig. 4. Mesangial cell viability measured by MIT absorbance assay (Meth-
ods). Puromycin alone (A— —A), puromycin and SOD (• — — •), puromy-
cm and catalase ('V — — V), puromycin and catalase and SOD (• •)
and puromycin and DPI (• •) are compared to control mesangial
cells. Mesangial cells were plated in 24-well plates and then treated with
various concentrations of puromycin with or without ROS scavengers for
a further 24 hours, after which a cell viability assay was performed. The
data points represent the mean the standard error of three experiments
performed in duplicate. *A significant (P < 0.02) difference in cell viability
between cells treated with puromycin alone and cells treated with the
various ROS inhibitors.
cells treated with increasing concentrations of puromycin there
was a progressive increase of rhodamine 123 fluorescence. More-
over, also shown in Figure 7, DPI inhibited the ROS production
stimulated by the addition of puromycin to mesangial cells. These
results provide strong evidence that puromycin increases produc-
tion of ROS by mesangial cells.
Discussion
Previous studies on the pathogenesis of PAN have tended to
focus almost exclusively on puromycin-induced changes in gb-
merular epithelial cells or the glomerular epithelial cell-glomeru-
bar basement membrane interaction, as being primarily responsi-
ble for proteinuria. In contrast, the mesangial cell is considered to
be "resistant" to these concentrations of puromycin. In fact,
puromycin sensitivity is widely used to distinguish between me-
sangial cells and glomerular epithelial cells under primary culture
conditions [21]. Notwithstanding these considerations, in the
present study we have demonstrated that puromycin, in concen-
trations similar to those that cause pathological changes to
glomerular epithelial cells in culture and in vivo, also result in
mesangial cell dysfunction. In particular the results of the present
study show that puromycin inhibits FBS-induced mesangial cell-
collagen gel contraction, an assay which reflects the integrity of
the interactions between the cell cytoskeleton and cell-substratum
attachments. Moreover, these effects of puromycin on mesangial
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Fig. 5. Reversal of the inhibito,y effect of puromycin (—•) on FBS-
induced MC collagen gel contraction by the addition of antioxidants SOD
(U—U), catalase (A— — A) and SOD and catalase (V — — Y). Mesangial
cells were embedded in collagen gels and % contractility calculated as
described in the Methods section. SOD (1000 pJml), catalase (0.4 mg/mI)
and the combination of the two reverse the inhibitory effect of puromycin
in a dose dependent manner. The data points represent the mean the
standard error of three experiments performed in duplicate. *A significant
(P < 0.02) difference in inhibition of gel contraction by puromycin when
treated with ROS inhibitors SOD and catalase.
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Fig. 6. Reversal of the inhibitory effect of puromycin (—•) on FBS-
induced MC collagen gel contraction by the addition of DPI (0.625 pM)
(U—U). MC were embedded in collagen gels and % contractility calcu-
lated as described in the Methods section. The data points represent the
mean the standard error of three experiments performed in duplicate.
*A significant (P < 0.02) difference in inhibition of gel contraction by
puromycin when treated with DPI.
Puromycin, pg/mi
Fig. 7. Mesangial cell induced dihydrorhodamine fluorescence changes
(Methods) following puromycin (5 pg/mI to 160 pg/mI) treatment (—•)
and after the addition of DPI (0.625 nM) (U U). The data points
represent the mean the standard error of three experiments performed
in duplicate. *A significant (P < 0.02) difference in fluorescence by
puromycin-treated mesangial cells, when compared to cells treated with
puromycin and DPI.
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cells are caused by a puromycin-mediated induction of increased
ROS production.
In the present study no morphologic evidence of puromycin
induced changes in actin filaments was found. In addition, micro-
tubules do not appear to be involved in the gel contraction assay.
Instead, the most likely cause of puromycin inhibition of FBS-
induced contraction is due to alterations at the level of mesangial
cell-extracellular matrix attachment or alterations in the cell
signaling processes that govern the mesangial cell-extracellular
matrix interaction.
The inhibitory effect of aminotriazole on FBS-induced mesangi-
al cell-collagen gel contraction and its reversal by catalase, as well
as the induction of gel contraction by DPI and catalase in the
absence of FBS, demonstrate that endogenous mesangial cell
ROS play a modulatory role in mesangial cell-collagen gel inter-
actions under normal steady-state resting culture conditions. ROS
have been shown to act as modulators of cell signaling in other cell
types. They have been shown to regulate tyrosine kinases in
neutrophils [22] and induce various gene products such as bcl-2
protein, which in turn modulates the toxic effects of ROS [23]. We
have not determined the mechanism whereby ROS affect the
mesangial cell-collagen gel assay; however, it is plausible that
ROS is similarly a regulator of cell signaling under these condi-
tions.
Although H202 would appear to be implicated, we have not
identified unequivocally which ROS are actually responsible for
the inhibitory effect on collagen gel contraction. The finding that
DPI reverses the puromycin changes implicates ROS formed by
—--I
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fiavoproteins as being at least in part responsible for the inhibitory
effect of puromycin on gel contraction. In contrast to the findings
of Diamond, Bonventre and Karnovsky [7], allopurinol did not
reverse the effect produced by puromycin. Consequently, it is
unlikely that production of ROS by the xanthine oxidase pathway
plays a significant role in our mesangial cell studies.
Although all effects of puromycin in the gel assays were
performed in the non-cytotoxic range, our study confirms that
mesangial cells in culture are more resistant to the cytotoxic
affects of puromycin than glomerular epithelial cells. Cytotoxicity
was noted at concentrations greater than 160 tg/ml in mesangial
cells compared to 25 ig/ml in glomerular epithelial cells [3]. At
concentrations greater than 160 g/ml the puromycin-induced
cytotoxicity of mesangial cells was reversed by the addition of
ROS inhibitors. This observation is similar to the earlier reported
effects of puromycin on glomerular epithelial cells in culture,
suggesting that the mechanism of injury in mesangial cell is similar
to that of glomerular epithelial cells, albeit at higher concentra-
tions of puromycin.
Resting mesangial cells produce basal rates of H202 of approx-
imately 0.4 nM per iO cells [241, which is significantly higher than
glomerular epithelial cells which produce almost no detectable
H202 levels in the resting state [3, 24]. Since mesangial cells have
a much greater potential to produce ROS than glomerular
epithelial cells, they may in fact be a more important source of
ROS than the glomerular epithelial cells in PAN nephrosis.
Consequently, the effects of enhanced mesangial cell ROS pro-
duction may not just be limited to changing mesangial cell-
extracellular matrix interactions, but could instead cause second-
ary damage to adjacent glomerular epithelial cells.
Puromycin has been shown to increase platelet activating factor
Fig. 8. Migratoiy cultured cells plated on plastic
substratum (S) spread and generate vectorial
forces (VA, VA') which originate from the elastic
nature of actin filaments. These forces are
transmitted to the substratum via attachment
loci (Bi, B2). The rigidity of the plastic in turn
generates vectorial forces (VC,VC') that
oppose the forces generated by the actin
filaments [21]. These two forces are opposite in
direction and equal in magnitude (VA + VA'
= VC + VC'). Thus, any reduction in the
forces of VC and VC' brought about by plating
cells on a flexible substrate (collagen I in this
study) results in VA + VA' > VC + VC',
leading to gel contraction. This contraction is
achieved by a newly created attachment point
(B') following the migratory movement (arrow
M) of the cell. The forces generated by actin
filaments pull the newly established attachment
P (B') to its original position (Bi), while the cell
remains attached to the substratum. Hence, in
order to achieve gel contraction, all the
following requirements must be fulfilled: (1) cell
spreading by elaborate actin filaments that
produce contracting forces; (2) cell migration
that permits formation of new cell-substratum
contacts; (3) cell-substratum attachment that
generate the necessary binding site for
transmission of forces to substratum; (4) fierible
substratum that allows shrinkage of the
substratum. Perturbation of any of the above
four requirements will inhibit gel contraction.
Abbreviations are: F, plasma membrane; N,
nucleus.
and tumor necrosis factor in cultured mesangial cells [25]; how-
ever, little else is known about the role of these cells in PAN. We
have shown that puromycin affects mesangial cell-interactions
with collagen gels. For gel contraction to occur mesangial cells
must be able to produce a force. The origin of this force is
complex and somewhat controversial, however, actin filaments
somehow play an important role [26] because their disruption, for
example by cytochalasin D, inhibits gel contraction [8]. Cell
migration is also a significant parameter and there must be an
intact cell-extracellular matrix interface in the form of a cell
adhesion molecule in order that the generated force be transmit-
ted to the gel [9]. Signaling pathways are necessary to regulate all
these the mesangial cell-ECM interactions.
Collagen gel contraction by mesangial cells can be induced by
various growth factors, hormones, vasoactive mediators and ex-
tracellular matrix components found in FBS [10, 11]. When
mesangial cells are embedded in extracellular matrix their ar-
rangement is unlike muscle tissue, and their immediate interac-
tion is with extracellular matrix rather than directly with adjacent
mesangial cells [26]. Mesangial cells in culture respond to agonists
which are known to induce smooth muscle contraction in vivo by
a reduction in their cell volume [14]. But this rounding up and
reduction in cell volume that is observed in culture systems and
often referred to as "contractility" is actually associated with a
reduction in contractile forces, hence inhibition of the gel con-
traction assay (Fig. 8). For example, cells treated with TGF-13
become flattened, exhibit enhanced expression of actin filaments
and induce contractility when embedded in collagen gels. In
contrast, dibuteryl cAMP and ROS causes the same cells to round
up and ultimately inhibits contractility in the collagen gel model
[14].
Actin filaments
A
B' I
* *
VC VA
Bi
VA' VC'
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The collagen gel assay is a useful model for elucidating the
physiological and pathological interactions between the mesangial
cell and extracellular matrix; however, the physiologic relevancy of
the assay is not established. In order to do so it is necessary to
reconcile the fact that agonists that act as vasoconstrictors in vivo
cause reduction in cell volume and decrease contractility in the gel
model. We propose the following mechanism: forces arising from
mesangial cell extracellular matrix interactions (Fig. 8) are trans-
mitted to the microfibrils [27] that connect the glomerular base-
ment membrane to the mesangial cell, and together they form a
biomechanical unit. Under resting conditions the resultant of
these forces maintains the capillaries in the open state. When cells
are exposed to "constrictor" agents, the actin filaments undergo
complex changes causing reduction in cell volume (rounding up)
leading to relaxation of the forces acting in the adjacent capillaries
with a consequent reduction of capillary diameter (that is, con-
striction). Within this model framework, mesangial cell-extracel-
lular matrix interactions could exert considerable influence on
glomerular filtration dynamics which in turn would influence the
ultrafiltration conditions in the glomerulus. Following the same
reasoning, the proteinuria of puromycin nephrotoxicity may not
only be caused by the cytotoxic effects of puromycin on the
glomerular epithelial cell (leading to detachment), but also may
be directly related to altered mesangial cell-extracellular matrix
interactions.
In conclusion, we have demonstrated that puromycin affects
mesangial cell-collagen gel contractility in concentrations similar
to those that cause morphological and cytotoxic changes of
glomerular epithelial cells in culture and that this effect is
mediated by ROS production. Based on our in vitro studies we
believe ROS act as modulators of mesangial cell signaling. The
effect of ROS production by the mesangial cells after exposure to
puromycin may not just be limited to the mesangial cell itself, but
may also influence the adjacent glomerular epithelial cells causing
glomerular epithelial cell toxicity and possibly glomerular epithe-
hal cell detachment. Thus, mesangial cells may play a more
important role in the pathogenesis of PAN nephrosis than has
heretofore been recognized.
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